Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs-Reference-Cited by-同舟云学术

Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs

Published:2016-08-04 Issue:8 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kayssi Ahmed¹,Al-Atassi Talal²,Oreopoulos George¹,Roche-Nagle Graham¹,Tan Kong Teng³,Rajan Dheeraj K³

Affiliation:

1. University of Toronto; Division of Vascular Surgery; Eaton North, 6th Floor, Room EN 6-214 200 Elizabeth Street Toronto ON Canada M5G 2C4

2. University of Ottawa Heart Institute; Division of Cardiac Surgery; 40 Ruskin Street Ottawa ON Canada K1Y 4W7

3. University of Toronto; Division of Vascular and Interventional Radiology; NCSB 1C-572, 585 University Avenue Toronto ON Canada M5G 2N2

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011319.pub2/epdf/full

Reference68 articles.

1. A prospective, multi-centre, randomized controlled, first in man study to assess the safety and performance of the Passeo-18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P-I) clinicaltrials.gov/ct2/show/NCT01221610

2. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial;Scheinert;Journal of Endovascular Therapy,2015

3. Tepe G Schulte K-L Zeller T Lammer J Pfaffinger P Schmidt A Six-month results of the BIOLUX P-I first in man study comparing a paclitaxel-releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions Cardiovascular and Interventional Radiology 2012 S264 5

4. Twelve-month results of the BIOLUX P-I first-in-man study comparing a paclitaxel-releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions;Zeller;Vasa - Journal of Vascular Diseases,2013

5. BIOTONIK's - first in men study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P-II) clinicaltrials.gov/ct2/show/NCT01867736

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-eluting devices for lower limb peripheral arterial disease;EuroIntervention;2024-09

2. Recent advances in targeted therapy for inflammatory vascular diseases;Journal of Controlled Release;2024-08

3. Robustness of Longitudinal Safety and Efficacy After Paclitaxel-Based Endovascular Therapy for Treatment of Femoro-Popliteal Artery Occlusive Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials;Annals of Vascular Surgery;2024-04

4. Research progress of drug eluting balloon in arterial circulatory system;Frontiers in Cardiovascular Medicine;2024-03-20

5. Knockdown of ARHGAP24 reduces intimal hyperplasia through inhibiting the proliferation and phenotypic switching of smooth muscle cells possibly by inactivating both AKT and ERK1/2 signaling pathways;Biochemistry and Biophysics Reports;2024-03